# AlloSource – FDA Inspection, Aug 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/allosource/2a5be685-c931-464a-b381-88ded2053088
Source feed: FDA_Inspections

> FDA inspection 1333098 of AlloSource, August 28, 2026. 6 citations under 21 CFR part 1271. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333098
- Company Name: AlloSource
- Inspection Date: 2026-08-28
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1201259 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/allosource/9feeb28f-e5dc-4eb3-8401-23c3664c6f22)
- FDA Inspection 1175639 - 2022-07-27
- [FDA Inspection 1074854 - 2018-12-18](https://www.keypedia.com/records/fda_inspections/allosource/bb193ac1-e1f8-4240-b903-129e24667479)
- [FDA Inspection 1010063 - 2017-02-09](https://www.keypedia.com/records/fda_inspections/allosource/be4789ed-58a8-46bc-953e-642b88c9f776)
- FDA Inspection 929703 - 2015-06-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)
- [FDA Personnel](https://www.keypedia.com/people/deepa-e-vadakkan/89c0e1c7-4f9e-4668-81a8-e5a9ab6a0e34)
- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)
- [Eric Zhu](https://www.keypedia.com/people/eric-zhu/32919a8f-841a-441b-a489-8495f2e16993)

Company: https://www.keypedia.com/companies/allosource/561511d2-2b9d-4a29-9565-deccb49a8455

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face